Permira is selling Australia's I-Med Radiology Network, which recently entered the U.S. by acquiring StatRad, to Hong Kong-based multinational conglomerate Jardine Matheson.
The Bedford, Massachusetts-based company has reportedly been approached about a possible acquisition by competitor Curium Pharma, Bloomberg reported May 22.
Artificial intelligence expert Nina Kottler, MD, with Rad Partners, explains the advantages of cloud-native artificial intelligence systems in medical imaging.
The House Ways & Means Committee on May 21 unanimously advanced the Provider Reimbursement Stability Act of 2026, which is endorsed by multiple radiology societies.
Whether MOC should be mandatory for all is often debated among providers, but new findings indicate that opting not to participate may affect patient care.
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.
A new analysis is prompting questions regarding how rigorously many of the AI-enabled tools approved by the U.S. Food and Drug Administration are evaluated prior to their clearance.